Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
about
Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.The use of intravenous antibiotics at the onset of neutropenia in patients receiving outpatient-based hematopoietic stem cell transplantsBloodstream infections in neutropenic cancer patients: A practical update.Supportive Care Costs Associated with Second-Line Chemotherapy in Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study.Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unitPrimary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and OncolThe prevention and management of infections due to multidrug resistant organisms in haematology patientsMultidrug-resistant bacteria in hematology patients: emerging threats.Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.Fluoroquinolone prophylaxis: worth the cost?Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice.Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
P2860
Q34667166-7EBD0103-F9DA-4BD8-9E3F-26ED7ED9B4E3Q36287292-6C973109-96FA-4CF7-8F46-7E8B4AC2D630Q36913345-D18E35DF-6647-4B4D-8ADB-EAEAD56C93E5Q36942871-586F62E1-1A7E-4BCE-8B05-458195B1D34DQ37628616-4CE863E0-1A15-4FA6-8155-36648E92B24FQ38081793-4AFA8029-F14C-4E50-9D62-36A3B33C7C53Q38171538-64F42F1B-09A2-4D47-8F26-E2163301A5DCQ38838498-935B62E0-FB47-4742-A479-BDFCBBAAAD21Q39024862-4BC9404D-DB40-4491-A4B4-59F286FEADC7Q40272325-E0324417-20D5-4D80-8448-E612B9E600C2Q40320980-A957863C-F553-41A7-A217-94E4054912C2Q40595836-9612B04A-023D-4443-8F48-103979841D5BQ50080905-D4C58F06-EF86-4A09-AEE5-67BEA537B8FA
P2860
Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Use of antibacterial prophylax ...... lines 2011 Steering Committee.
@en
type
label
Use of antibacterial prophylax ...... lines 2011 Steering Committee.
@en
prefLabel
Use of antibacterial prophylax ...... lines 2011 Steering Committee.
@en
P2093
P2860
P1476
Use of antibacterial prophylax ...... elines 2011 Steering Committee
@en
P2093
Australian Consensus Guidelines 2011 Steering Committee
D S Ritchie
L Mileshkin
S Lingaratnam
P2860
P304
P356
10.1111/J.1445-5994.2010.02341.X
P577
2011-01-01T00:00:00Z